Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
4 studies found for:    stemedica

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
Condition: Ischemic Stroke
Intervention: Biological: Allogeneic adult mesenchymal bone marrow stem cells
2 Recruiting A Phase IIa, Single-blind, Placebo-controlled, Crossover, Multi-center, Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Heart Failure of Non-ischemic Etiology
Condition: Non-ischemic Heart Failure
Interventions: Drug: Human Allogeneic Mesenchymal Stem Cells;   Drug: Placebo
3 Not yet recruiting Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging
Conditions: Intrinsic Aging of Skin;   Chronic Effect of Ultraviolet Radiation on Normal Skin (Photo-aging);   Dermatologic Disorders
Intervention: Biological: Allogeneic Mesenchymal Bone Marrow Cells
4 Active, not recruiting A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)
Conditions: ST Segment Elevation Myocardial Infarction (STEMI);   Allogeneic Mesenchymal Bone Marrow Cells
Intervention: Biological: Stem cells
To Top

† Indicates status has not been verified in more than two years